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Summary 
 Solid tumors require the formation of new blood vessels to support their growth,  invasiveness 
and metastatic potential. Tumor neovascularization is achieved by vasculogenesis from endothelial 
precursors and by sprouting angiogenesis from preexisting vessels. The complex sequence of events 
driving these processes, including endothelial activation, proliferation, migration and differentiation, is 
associated with fluxes of ions, water and other small molecules mediated by a great pool of ion channels 
and transporters (ICT). This ‘transportome’ is regulated by environmental factors as well as intracellular 
signaling molecules. In turn, ICT play a prominent role in the response to angiogenesis-related stimuli 
through canonical and 'unconventional' activities: indeed, there is an increasing recognition of the 
multifunctionality of several ion channels that could also be annotated as receptors, enzymes, 
scaffolding proteins, mechanical and chemical sensors. 
The investigation of ICT structure and function has been far from the experimental oncology for long 
time and these two domains converged only very recently. Furthermore, the systems biology viewpoint 
has not received much attention in the biology of cancer transportome. Modulating angiogenesis by 
interference with membrane transport has a great potential in cancer treatment and the application of 
an 'omics' logic will hopefully contribute to the overall advancement in the field.  
This review is an attempt to apply the systems biology approach to the analysis of ICT involved 
in tumor angiogenesis, with a particular focus on endothelial transportome diversity. 
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Introduction 
Over the last thirty years, much insight has been gained into the central role of the endothelium 
in human health and disease (1). Endothelial cells (EC) represent a great evolutionary novelty in 
vertebrates (2–5): they line the blood vessel and act as a dynamic interface between blood and tissues 
providing a powerful control system for blood pressure and remodeling of vascular network (6). Since 
the endothelium can be a target or a causal factor of human disease, its assessment is a valuable tool in 
clinical investigation (1). The integrated evaluation of endothelial function and dysfunction 
incorporating, for example, coagulation, inflammatory, and vascular tone properties in normal 
homeostasis and diseases led some authors to propose the concept of 'endotheliome' (7). This term 
refers to endotheli-al form and function as a whole (-ome): a key requirement is to forge a synthesis of 
the array of endothelial vascular modifications in function of time and to understand how they are 
required for a given function or dysfunction to occur.  
 The formation of new blood vessels is required during tissue growth and remodeling in order to 
provide adequate nutrients and oxygen and overcome the basic surface/volume constraint in biological 
processes. Neovascularization can occur through different mechanisms such as vasculogenesis from 
endothelial precursors and sprouting angiogenesis (8). During this process endothelial homeostasis is 
regulated by pro- and anti-angiogenic factors: the response to these extracellular stimuli depends, 
among the other proteins, on the plasma-membrane transportome, the great and diversified tool of ion 
channels and transporters (ICT) expressed in the plasma membrane of EC (9). Neovascularization 
actually involves activation, proliferation, migration and differentiation of EC and endothelial cell 
precursors (EPC): all these events are associated with fluxes of ions, water and other small molecules 
mediated by a great variety of ICT (10,11). The growing interest on the contribution of ICT is clearly 
revealed by the huge number of very recent reports and reviews focused on this topic and published in a 
broad range of journals (10,12–17).  
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 The transportome is finely regulated by a large pool of intracellular and extracellular signals, 
respectively, including signaling/metabolic pathways and soluble pro- and anti-angiogenic peptides, 
hormones, as well as extracellular matrix components. In turn, they mediate the vascular responsiveness 
to vasoactive stimuli. Intriguingly, this role is not always played by their canonical activity: indeed, as 
discussed below, a number of ion channels exhibit non-conductive functions and could also be 
annotated as receptors, enzymes, scaffolding proteins, mechanical and chemical sensors (18–23). 
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ICT expression during normal and altered angiogenesis 
Globally, the main aims for a systems biology of ICT in altered angiogenesis should be 1) a clear 
definition of the endothelial transportome and 2) a deep knowledge of its integration with cell signaling 
and metabolome (the complete set of small molecule metabolites found within a cell compartment) 
involved in patho-physiological neovascularization: the latter issue is strictly related to protein 
interactomics (Figure 1). 
To address the first goal we need an exhaustive annotation of the entire pool of ICT expressed by EC 
and EPC, their topological distribution and a description of the great variability due to genetic and 
epigenetic factors, including tissue microenvironment. The readout of this approach would be 
particularly attractive for vascular biology due to the great diversity found in normal and tumor-
associated vessels and endothelial cells (24,25).  
Despite the importance and the increased utility of proteomic tools in medical research for 
extending basic understanding in vascular biology and for directing the delivery of therapeutic and 
imaging agents in vivo, endothelial proteomics is only at its beginning. In addition, global ontology 
analyses are required to move beyond a simple list of proteins and to understand better how they 
interact and function in a given environment, providing a validation of a proteome generated from 
large-scale mass spectrometry (MS) analysis. This would lead to a better knowledge of the relationship 
of proteins in a functional network, as well as to the detection of novel functions and pathways in the 
given tissue (26). 
Unfortunately, profiling the plasma membrane proteome (also named 'plasma membranome', 
e.g. the pool of proteins embedded in plasma membrane lipid bilayer) by the use of standard large-scale 
methods including MS-based strategies has been limited by problems associated with extraction, 
solubilization, and identification of intrinsic membrane proteins in cells and tissues. Moreover, ECs 
form a thin monolayer lining each blood vessel. They constitute a very small fraction of all the cells in 
the tissue, making it difficult to isolate pure EC plasma membrane fractions for proteomics analysis 
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using conventional sub-cellular fractionation techniques. Although relatively simple to isolate from 
tissue and grow in culture, EC require microenvironmental components to maintain their tissue-
specific qualities and thus undergo undesired phenotypic changes after isolation. Mass spectrometry 
(MS) measurements and the use of multiple analytical methods can greatly expand the 
comprehensiveness of endothelial proteomic profiling. However, the inherent biases and variations in 
such data limit the quality of a quantitative comparative analysis.  
A recent comparative analysis of EC plasma membranome employed four different MS-based 
strategies involving 2-D and 3-D separation (26). It combines protein pre-fractionation via SDS-PAGE 
with in-gel digestion to produce peptides separated by one- and two- dimensional nano-HPLC before 
seamless and continuous MS analysis. Each method used multiple replicate measurements to 
comprehensively identify proteins, achieving a clear statistical definition of completeness that allows 
meaningful comparisons. This approach greatly expanded the EC plasma membranome to 1,833 
proteins of which nearly 30% are membrane-embedded (26,27). A further unbiased systems analysis 
unraveled the related pathways and functions including cell surface signaling networks, cytoskeleton 
organization, adhesion, membrane trafficking, metabolism, mechanotransduction, membrane fusion, 
and vesicle-mediated transport (28). 
 Only a few studies incorporate proteomic analysis of freshly isolated ECs from healthy and 
altered tissues or conditions that mimic key angiogenic variables, such as oxygen tension and shear stress 
(25).  
We should take into account that the endothelium lining blood vessels and surrounding stroma 
in tumors differs from normal one, but only recently these differences have begun to be characterized at 
the molecular level (29–31). Since angiogenesis is required for physiological processes, markers that 
distinguish normal and pathological vasculature are needed in order to selectively deliver antiangiogenic 
agents to diseased tissues minimizing the potential side effects. A proteomic method has been developed 
to discover cell surface/secreted proteins, as they represent key antibody therapeutic and biomarker 
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opportunities (32). It is based on flow cytometric staining of vascular organs with known endothelial 
markers and their purification by cell sorting. Upon cell surface protein capture and tryptic digestion, 
the resulting proteolytic peptides are subjected to liquid chromatography – mass spectrometry (LC/MS) 
to identify the proteins. The comparative analysis revealed differences in the expression in different 
organs or conditions. Tumor-derived endothelium obtained from the kidney, lung and colon 
overexpresses more than one hundred of proteins when compared with normal surrounding tissues (32). 
Interestingly, ATP1B3 was among the more differentially expressed cell surface tumor-specific 
endothelial markers identified in this study. ATP1B3 belongs to the family of Na+/K+-ATPases, integral 
membrane proteins responsible for establishing and maintaining the electrochemical gradients of Na+ 
and K+ ions across the plasma membrane. This enzyme is composed of two subunits, a large catalytic α 
subunit and a smaller β glycoprotein (33). The β subunit regulates, through assembly of α/β 
heterodimers, the number of Na+/K+ ATPases transported to the plasma membrane. Recent studies 
indicate that the α- and β-subunits might independently be involved in cellular functions other than 
ion pumping (34). For example, the β-subunit could play a role in cell-cell adhesion. The amounts of 
the cell surface β-subunits increase when the cell density becomes higher, whereas the amount of the 
α−subunit does not change significantly (34). Further studies are needed to unveil the functional 
outcome of ATP1B3 over-expression on tumor vasculature (32).  
Another proteomic work was undertaken on human telomerase-immortalized dermal 
microvascular endothelial cells (TIME) in order to identify key regulatory events at the protein level 
during tubular morphogenesis in vitro (35). Curiously, one of the VEGF-A-regulated EC proteins was 
identified as chloride intracellular channel 4 (CLIC4). The CLIC proteins have the unusual ability to 
translocate from the cytoplasm to various cell membranes and their overexpression promotes plasma 
membrane localization where they act as functional anion channels. CLIC4 has also been shown to 
engage in complex formation with cytoskeleton components such as actin, tubulin, and dynamin I. The 
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ability of CLIC4 to modulate the activity of cell surface ICT in retinal pigment epithelium-
photoreceptor adhesion raises the possibility for a similar role in vascular endothelium (36). 
 Although many compounds have entered clinical trials as modulators of tumor angiogenesis, the 
conventional anti-angiogenic therapies based on well established molecular targets such as VEGF, 
integrins and angiopoietin, suppress neovascularization only transiently: they suffer from the so-called 
‘tumor escape phenomenon’, due to compensating pathways that circumvent the initial effect, as well as 
from ‘resistance’ to chemotherapy drugs (30,37–40). Intriguingly, the combination of anti-VEGF 
therapy with conventional chemotherapy has improved survival in cancer patients compared with 
chemotherapy alone. These seemingly paradoxical results have been explained by a 'normalization' of 
the abnormal tumor vasculature usually characterized by dilated, tortuous, and hyperpermeable vessels. 
Vascular normalization leads to an attenuation of hyperpermeability, increased vascular pericyte 
coverage, a more normal basement membrane, and a resultant reduction in tumor hypoxia and 
interstitial fluid pressure (41–43). These in turn can lead to an improvement in the metabolic profile of 
the tumor microenvironment, the delivery and efficacy of exogenously administered therapeutics, the 
power of radiotherapy and of effector immune cells, and a reduction in number of metastatic cells. An 
omics approach in models of EC normalization, taking into account also other stromal cells such as 
fibroblasts and immune cells, could shed more light on the mechanisms underlying this promising 
effect. The putative contribution of ICT in vascular normalization is unknown but the field is in need 
of alternative targets, related to the identification of novel and missing angiogenesis annotations and 
their association with vascularization by the use of statistical analysis and multiple gene expression 
datasets. GeneHits is a method that combines graph diffusion kernels from PPI and pairwise 
associations from protein domain occurrence to construct a global angiogenesis protein interaction 
network, called 'Angiome' (44,45). An initial network of 478 proteins was then extended to 1,233 
proteins. The angiome allows one to identify those genes and proteins in the databases that are 
associated with angiogenesis by comparing the disease- or condition-specific data to the angiome. 
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Examples may include identification of specific angiogenesis-associated genes that are up- or 
downregulated or mutated in disease conditions. Some of them may then be considered as putative 
targets for therapeutic approaches that, ultimately, will need to be experimentally validated. The human 
interactome was recently integrated with known angiogenesis-annotated proteins to identify a set of 202 
angiogenesis-associated proteins in different cell lines (46). The expression of several proteins turned 
out to be highly perturbed during angiogenesis. Upon exposure to VEGF-A, some proteins were 
upregulated, such as HIF-1α, APP, HIV-1 tat interactive protein 2, and MEF2C, whereas endoglin, 
liprin β1 and HIF-2α resulted downregulated. The analysis showed differential regulation of HIF-1α 
and HIF-2α (46). 'Angiome' database doesn't include yet information about ICT, whose 
implementation will hopefully cover this lack.  
Despite the fact that these high-throughput and large-scale approaches reveal very powerful and 
increasingly robust, they are still poorly employed in the field of membrane transport. Most of the 
available information on the differential expression pattern of transportome is actually obtained from 
small-scale hypothesis-driven works. Two well described examples involve some members of the 
Transient Receptor Potential (TRP) channels and Orai1 that form calcium-permeable channels. Among 
the 30 mammalian TRP channels, at least 19 are expressed in vascular ECs and are suggested to 
participate in a wide range of vascular functions, including control of vascular tone, permeability, 
mechanosensing, vascular remodeling and angiogenesis (47). However, in spite of the large body of data 
available, the functional role of many endothelial TRP channels in normal and neoplastic angiogenesis 
is still poorly understood. Transient receptor potential vanilloid 4 (TRPV4) is a calcium channel 
involved in EC migratory potential and is overexpressed in human breast-carcinoma derived EC 
(BTEC) compared to healthy EC (48). Canonical transient receptor potential channel 1 (TRPC1), as 
well as another calcium channel, Orai1, is upregulated in endothelial progenitor cells (EPC) isolated 
from renal carcinoma patients compared with EPC from healthy patients (14,49,50). Both these cases 
will be largely discussed in the following chapter (12,13,15–17). Growing evidence supports the 
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evidence that cancer cells may drive endothelial changes by exploiting their high flexibility. In particular, 
tumoral microenvironment has the ability to greatly influence the drug-resistance of ECs through 
molecular mechanisms still poorly understood. A recent paper postulated that microvessels (MV) 
derived from MCF-7 adriamycin-resistant cells (MCF-7/ADM) communicate with and influence the 
resistance of HMECs acting as a 'cargo' in cell-cell communication. MCF-7/ADM cell-derived MVs 
transfer TRPC5 to HMECs, inducing the expression of P-glycoprotein (P-gp) by activation of the 
transcription factor NFATc3 (nuclear factor of activated T cell isoform c3) (51). The TRPC5-
dependent upregulation of P-gp is suggested to be tighly associated with Ca2+ entry induced by 
functional TRPC5 ion channel, but only further investigations will provide more mechanistic details on 
this intriguing process: blocking TRPC5 could contribute to overcome drug-resistance in cancer. 
The altered expression panel of tumor-associated ICT does not involve only calcium channels, 
as suggested by the aberrant level of potassium channels encoded by the human ether-a-go-go related 
gene (Kv11.1, or hERG1) that regulate vascularization in some human cancers (52–54).  
Another very interesting issue is related to the membrane permeability for water. Among the 
membrane fluxes that play a universal and conserved role in cell physiopathology, water permeation is 
highly relevant being a direct regulator of intracellular osmoticity and volume. Aquaporins (AQPs) are 
the integral plasma membrane proteins involved in water transport in many fluid-transporting tissues. 
Cancer cells express AQPs and a positive correlation exists between histological tumor grade and the 
AQP expression (55,56). In particular, AQP-1 plays a crucial role in tumor angiogenesis and regulates 
EC migration (57–61). Deletion of AQP-1 in genetically modified mice reduces tumor angiogenesis 
(57). In AQP-1 knockout mice, implanted tumors grow slowly and are less vascularized than in wild-
type mice, indicating that cancer neovascularization and growth are promoted by endogenous AQP-1. 
On the other hand, the evidence that these mice develop normally with no detectable vascular defects 
strengthens the idea that normal and tumor angiogenesis are governed in different ways. Furthermore, 
microarray analysis has revealed that the AQP-1 gene is upregulated by estrogen and plays a crucial role 
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in estrogen-induced tubulogenesis of HUVEC possibly contributing to vascular permeability increase 
seen in response to the hormone mediated by the upregulation of VEGF and its receptors (60,62–64).  
 
Interactomics of vascular ICT 
Databases  
 A global map of protein-protein interactions (PPI) in cellular systems provides key insights into 
how an organism works as a whole. Indeed, human diseases are rarely the consequence of an isolated 
abnormality in a particular gene but are usually the outcome of complex perturbations of the 
underlying molecular network. This has led to systematic studies of interactome networks, whose 
structure is governed by key graph theoretical laws, where the probability of observing a protein with a 
small number of interactions is higher than the probability of observing a protein with many 
interactions (65).  
Several public databases allow interactive investigation of interactome, including String-db, Genehits, 
Uniprot, Biogrid, DIP, IntAct, Reactome, Pathwayscommons, Pathway Interaction Database, and 
Unihi (65). A repository of well-validated high-quality PPI can be used in both large- and small-scale 
studies to generate and validate a wide range of functional hypotheses. The pattern of binary 
interactions can be obtained by literature-curation (LC) and high-throughput experiments (HT) (66). 
LC refers to systematically collecting interaction data from small-scale studies while HT experiments 
produce large-scale interaction maps. Because most LC data are generated by hypothesis-driven 
experiments, it is much easier to infer biological function from those studies as compared to HT 
experiments (66). 
Despite the quality of this approach being widely questioned, the reproducibility of large-scale protein 
interaction results has much improved. Moreover, common data standards and coordinated curation 
practices between the databases that collect the interactions have made these valuable results available to 
a wide community of researchers (65). Nonetheless, it is not easy to reconcile information from 
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different independent and not-coordinated sources. For this reason, a number of them joined in 
International Molecular Exchange consortium (IMEx) to provide a unique standard curation practice 
and data presentation (67). 
 Interaction databases may lead to different predictions whose accuracy can be improved by 
incorporating datasets on organ- and cell type-specific gene expression, and by obtaining additional 
independent experimental evidence (68). A recent survey evaluated the characteristics of six interaction 
databases, incorporated tissue-specific gene expression information and then investigated if the most 
popular proteins of scientific literature are involved in good quality interactions (68). The databases 
result comparable in terms of node connectivity (i.e. proteins with few interaction partners also have 
few interaction partners in other databases), but may differ in the identity of interaction partners. 
Moreover, the incorporation of tissue-specific expression information significantly alters the interaction 
landscape and many of the most intensively studied proteins are engaged in interactions associated with 
low confidence scores.  
 An advanced systems biology of vascular ICT in angiogenesis aims at investigating the network 
of physical and biochemical PPI at two levels: the multimeric ICT assembly and, more broadly, PPI 
occurring between membrane transportome and proteins canonically associated with other functions 
such as cell signaling and metabolism. This second level would help to explain how channels and 
transporters integrate and coordinate intracellular pathways as well as how ICT are regulated by 
signaling proteins, lipids, and gasotransmitters (69–75). Accordingly, defective interactions of protein 
partners with ICT represent alternative mechanisms of membrane channelopathies (76). Molecular 
interactions actually create local microenvironments that can modify the functional properties of ICT. 
The assemblies built around a transporter or channel, called 'transportsomes' and 'channelosomes', can 
be considered as functional units even if they are difficult to purify and reconstitute, posing a significant 
challenge in the investigation of their functional role (77,78). A special issue on 'Channels' provides an 
overview of the nature and function of transportsomes and channelosomes (77). Successful studies 
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focusing on PPI could potentially lead to new drug discovery strategies targeting ion channel complexes 
(79).  
 As already mentioned, the interactome dynamics is strictly related to the physiological or altered 
cellular targeting of ICT. Indeed, the actual functions and biological effects of ion-transport-related 
proteins critically depend upon their intracellular distribution and, consequently, their interaction with 
a specific pattern of other proteins (specific interactome). The term 'interaction' refers to direct physical 
protein-protein (first-order) binding detectable by yeast-two-hybrid and protein complementation 
assays, as well as to indirect interaction through the mediation of other components, including 
scaffolding proteins, detectable by affinity purification followed by mass spectrometry (65). In some 
cases PPI are associated with post-translational modifications that drive cell signaling, such as 
phosphorylation, nitrosylation, sulphydration, redox reactions, and palmitylation.  
 According to this well-established knowledge, a more integrative view of ICT is now required, 
that should be investigated as components of the global vascular proteome involved in angiogenesis. 
The application of such a systems biology approach, that is experiencing its initial stage in this 
particular field, will hopefully open new exciting directions in both basic and biomedical biology.  
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Angiogenesis-related channelosomes 
Among the channels that play remarkable roles in tumor vascularization, the aforementioned 
Transient Receptor Potential (TRP) proteins are the best known and their functions are regulated 
through interaction with many cellular proteins (70,80,81). The TRIP (Transient receptor potential 
channel-Interacting Protein) manually curated database has been recently developed, that aims to offer 
comprehensive information in the field (78,82,83). According to the broad considerations discussed in 
the previous chapter on interactome databases, great attention should be devoted in order to extract 
suitable unbiased information. Indeed, not all TRPs and their interactors are simultaneously expressed 
in a cell; PPI may occur only in a specific biological microenvironment; a TRP-binding protein 
concurrently interacts with multiple TRPs in a given cell at a specific condition; moreover, TRP-
interacting proteins may competitively bind to the same region of a TRP channel. Given that 
interactions can dynamically modify the activities and subcellular locations of TRP, cell type- or cell 
context-specific PPI data are required to reveal the physiological relevance of TRP interactome in a 
more integrated viewpoint. Such data can be harvested by omics experimental approach under cell type- 
or cell context-specific conditions or computational integration of TRP channel PPI data with gene 
expression profile data.  
TRP channels assemble into homomeric or heteromeric tetramers (84). The latter complexes are 
formed among the isotypes within or across subfamilies, suggesting a high-order complexity of TRP 
channel regulation in a physiologic context. Though not fully characterized, some evidence shows that 
new biophysical properties are created by heteromerization between TRP channel isotypes, including 
TRPC1-TRPC3, TRPC1-TRPC4, TRPC4-TRPC5, TRPC1-TRPC5, TRPC1-TRPP1, TRPC1-
TRPV4, TRPV4-TRPP1, TRPV5-TRPV6, TRPML1-TRPML2, and TRPML1-TRPML3 (84,85). 
TRPC1 interacts physically with TRPV4 to form a complex that mediates flow-induced and store-
operated calcium entry (SOCE) in primary mouse aortic and human HUVEC (86,87). Endothelial 
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SOCE involves signalplexes embodying Orai1, Stim1 and TRPC1 and regulates critical vascular 
processes, remodeling and angiogenesis (85,88).  
Functional SOCE is also present in human circulating endothelial progenitor cells (EPCs), a 
sub-population of mononuclear cells that is recruited from either bone marrow or arterial wall to 
replace damaged/senescent EC and recapitulate the vascular network of lesioned organs. They act by 
either stimulating local angiogenesis via paracrine signaling or by physically engrafting within neovessels. 
SOCE controls proliferation and in vitro tubulogenesis in EPCs isolated from both peripheral and 
umbilical cord blood of healthy donors (N-EPC). Notably, SOCE is upregulated, mitogenic and 
protubulogenic for EPCs isolated from peripheral blood of patients affected by renal cellular carcinoma 
(RCC-EPC) (14,49,50,89). The enhanced SOCE in these cells is associated with the over-expression of 
Stim1, Orai1, and TRPC1 (49,50,89). N-EPCs possess TRPV4, which plays a master signaling role in 
mature healthy and tumor-derived endothelium, by controlling both vascular remodeling and arterial 
pressure (90). TRPV4 mediates cell migration of BTEC (but not HMEC) via arachidonic acid-
activated actin remodeling (91). The role of TRPV4 in EPC is unknown, but it is not involved in the 
control of cell proliferation (90). Surprisingly, both N-EPC and RCC-EPC lack TRPC3, TRPC5 and 
TRPC6 that play critical functions in mature endothelium (11,12,16,17). Endothelial colony forming 
cells isolated from patients with primary myelofibrosis (PMF-ECFCs) undergo a distinctive remodeling 
of the Ca2+ machinery: Stim1, TRPC1, TRPC4, Orai3 and, perhaps, Orai2 proteins are up-regulated 
and, unlike N- and RCC-ECFC, the InsP3-dependent SOCE does not drive PMF-ECFC proliferation 
(92).  
 An overview of the current state and future directions of TRP channel network biology is 
reported in (78).  
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Interactions between ICT and cytoskeleton 
Some ion channels and transporters bind to members of the large family of proteins that 
constitute the cytoskeleton (21,93). This sub-network underlies the endothelial mechanosensitivity and 
transduction during sprouting angiogenesis (21,94,95). 
TRP channels. TRP channels selectively associate with the cytoskeleton (96). Many of them 
include ankyrin repeat domains, 33-residue motifs consisting of pairs of antiparallel α-helices connected 
by β-hairpin motifs, that link proteins, such as InsP3R or NHE, to the cytoskeleton. The occurrence of 
such domains is differently pronounced within the TRP family but their function is still poorly 
understood (70). The relationship between TRP proteins and cytoskeleton is bidirectional, with a role 
of ion fluxes in the rearrangement of the cytoskeleton structures and, in turn, the activity of the 
cytoskeleton and associated proteins in supporting the appropriate TRP targeting, PPI and channel 
gating (96).  
Furthermore, TRP channels are part of macromolecular complexes including different signal 
transduction proteins involved in a variety of cell functions (77). A relevant example is the role of the 
scaffolding proteins belonging to the families of Homer and INAD that regulate TRPC channel gating 
(96). Intriguingly, TRP themselves can act as scaffolding proteins. Recent analysis of the function of 
TRPC4 in vascular EC of divergent phenotype revealed a novel aspect of TRPC signaling, extending 
the current concept of TRPC regulation by a phenotype-dependent switch between Ca2+ transport and 
a potential intracellular scaffold function of the TRPC protein (97). TRPC4 contains six 
transmembrane domains and its cytosolic C terminus includes several binding domains that tether 
TRPC4 to the membrane skeleton. A functional mammalian INAD homologous protein was identified 
by the characterization of peptide sequences of NHE Regulatory Factor (NHERF) and the subsequent 
identification of TRPC4 and TRPC5 as potential interaction partners (98). NHERF was originally 
isolated as a factor required for inhibition of NHE type 3 (NHE3) mediated by PKA (99). The protein 
has two PDZ domains, the first one recognizing peptides carrying T-R-L at the C-terminus. The 
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sequences of the mammalian TRPC4 and TRPC5 also end with the T-R-L motif. The activation mode 
of the TRPC4/5 complex is still an issue of controversy. Some groups proposed a store-depletion 
mechanism, while other laboratories reported the activation of TRPC4/5 to be dependent on 
receptor/G-protein/PLC activation, but independent of store depletion (100). PDZ1 of NHERF1 
binds to TRPC4 and TRPC5 heterologously expressed proteins (98). The interaction of two partners 
with the same PDZ domain suggests a model in which NHERF forms a homodimer via PDZ2 and 
PDZ1 domains, bringing TRP channels (TRPC4, TRPC5) in proximity of PLC (98). Like INAD, 
which controls function, stability, and plasma membrane expression of Drosophila TRP, NHERF 
regulates TRPC4 targeting.  
A model of TRPC4 embedded in its signaling scaffold has been proposed in pulmonary artery 
EC (PAEC) (101): TRPC4 interacts directly with protein 4.1 through its protein 4.1 binding domain, 
as well as with NHERF, linked to actin through ezrin-radixin-moesin (ERM) proteins. NHERF is a key 
scaffolding protein in that it can also bind directly to PLC and G-protein–coupled receptors through its 
PDZ domains. The signaling assembly is localized in cholesterol-rich caveolae containing caveolin-1, a 
binding partner for different ion channels (see below) (101). In the same cells TRPC4/Orai1 coupling 
controls TRPC1/4 activation and channel permeability, including Ca2+ selectivity, and the ensuing 
endothelial cell barrier function (102,103). It is worth noting that, although Orai1 expression is usually 
associated with its canonical function as a Ca2+ channel, growing evidence suggests that Orai1 and 
Orai3 proteins may be more important than Ca2+ influx to control proliferation of different cell lines 
(104). Intriguingly, thrombin-mediated decrease of transendothelial electric resistance (TER), a marker 
of endothelial barrier disruption, requires Stim1 independently of Orai1 and Ca2+ entry across the 
plasma membrane in HUVECs and HMVECs. The regulation of endothelial barrier function may not 
be due to Stim1-mediated interaction with TRPC channels. Rather, Stim1 seems to be required for 
RhoA activation, MLC phosphorylation, and formation of actin stress fibers (105). Other TRPC4 
interactors are the large molecular weight immunophilins FKBP51 and FKBP52 that respectively 
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inhibit and enhance TRPC4-related SOCE in PAECs (106). As discussed below, TRPC4 is critically 
involved in the regulation of EC permeability by Thrombin (107). In HMEC TRPC4 is regulated by 
cell-cell contact formation and interacts with β-catenin, and the related Ca2+ entry acts in a specific 
endothelial state during the transition from a proliferating to a quiescent phenotype. Hence TRPC4 
may adopt divergent functions in endothelial Ca2+ homeostasis and emerges as a potential key player in 
endothelial phenotype switching and tuning of cellular growth factor signaling (108). 
Cyclic mechanical strain produced by pulsatile blood flow regulates the orientation of EC lining 
blood vessels and contributes to the control of angiogenesis. It has been reported that flow-induced 
stretching activates mechanosensitive TRPV4 that, in turn, stimulates PI3K-dependent activation and 
binding of additional integrin receptors, which promotes cytoskeleton remodeling and cell reorientation. 
Inhibition of integrin activation using blocking antibodies and knockdown of TRPV4 channels with 
specific siRNA suppress strain-induced capillary cell reorientation (109). A direct interaction between 
TRPV4, α2 integrin and the Src tyrosine kinase Lyn has been reported in sensory neurons (110), 
raising the possibility that TRPV4 could reside in a common mechanosignaling complex with 
extracellular matrix (ECM) receptors also in endothelium.  
Other interactors of integrins are potassium channels. In particular, hERG1 are frequently 
found aberrantly expressed in tumors (see above) and control different aspects of the neoplastic cell 
physiology: they trigger and modulate intracellular signaling cascades through the assembly of 
multiprotein membrane complexes which also recruit integrin subunits and receptors for growth factors 
or chemokines (52,53,111). Therefore, hERG1 may be a key component of the ‘functional hubs’ that 
control angiogenesis in cancer. The microenvironment, through the functional interplay between 
integrins and hERG1, regulates angiogenesis and tumor progression possibly contributing to VEGF 
resistance (13,52,111,112). A signaling pathway that sustains angiogenesis and progression in colorectal 
cancer cell lines has been proposed in which β1 integrins and hERG1 channels form a functional 
plasma membrane complex able to recruit and activate PI3K and Akt. This event in turn increases the 
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Hypoxia Inducible Factor (HIF)-dependent transcription of VEGF-A and other tumor progression 
genes. Similarly, VEGFR-1 (FLT-1), β1 integrin, and hERG form a macromolecular signaling complex 
in acute myeloid leukemia (113). 
Aquaporins. As mentioned before, water fluxes mediated by Aquaporins are involved in tumor 
angiogenesis. Presumably AQP1, which is specifically and strongly expressed in most EC of the 
microvasculature outside the brain (114), seems to act not only as a water channel but it contributes to 
cell migration (57,115). In two different cell lines expressing AQP1, the human melanoma cell line 
WM115 and the human microvascular cell line HMEC, the knock down of AQP1 promotes a re-
organization of F-actin and affects the cell shape (115). In non-silenced cells F-actin is preferentially 
polarized at the leading edge of the plasma membrane and the cells produce tubules in vitro (115). In 
contrast, AQP1-silenced cells loose significantly their tubulogenic potential and decrease their ability to 
migrate (115). Actually, the polarization at the leading edge of migrating cells has been demonstrated 
for several transporters involved in migration, including Na+/H+ and Cl-/HCO3- exchangers and the 
Na+/HCO3- co-transporter, and cell migration involves the transient formation of lamellipodia and 
plasma membrane ruffles at the leading edge of the cell, suggesting that a rapid local changes in ion 
fluxes and cell volume are accompanied by rapid transmembrane water movement (116). Thereby, the 
actin cleavage and ion uptake at the tip of lamellipodium might create local osmotic gradients that drive 
the influx of water across the plasma membrane. Saadoun et al. postulated that water entry increases 
local hydrostatic pressure causing the polarization of AQP1 (57). The intracellular mechanisms 
triggered by AQP1 are not well known, but it has been recently shown that Lin-7 co-
immunoprecipitates with AQP1 and interacts with β-catenin through Lin-7, affecting the organization 
of cytoskeleton (115). Intriguingly, the lack of AQP1 leads the Lin-7/ β-catenin complex to proteolytic 
degradation (115). Altogether, these data suggest that the physiological role of AQP1 goes beyond its 
water transport function. This protein rather emerges as a critical scaffold for a plasma membrane 
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associated multi-protein complex critical for endothelial cytoskeleton build-up, adhesion and motility 
(115).  
Other TRP interactors. 
 A number of interacting proteins bind to different TRP members, such as of caveolin 1, 
calmodulin, Src, and IP3 receptor 3 (IP3R3). This sub-network offers the potential functional link to 
human diseases. For example, the oncogene Src interacts with nine TRP members, including TRPV1, 
TRPC6 and TRPV6: all of them are associated with cancer progression and the first two with tumor 
angiogenesis (12,16,17,78).  
Caveolin-1 is a particular plasma membrane binding partner for a number of ion channels. A work 
conducted on HMEC and endothelium from CAV-1-/- mice reported that Cav-1 scaffold domain 
interacts with TRPC1 and IP3R3 to regulate SOCE (117,118). TRPC1 is embedded in a protein 
complex that can include IP3R, homer, calmodulin, caveolin-1, FKBP25, I-mfa, MxA, GluR1α, 
bFGFR-1, Gq/11 protein, phospholipase C-β/γ, protein kinase C-α and RhoA (119).  
An integrated functional example is given by the role of TRPC1 in the regulation of thrombin-
mediated endothelial permeability. Thrombin binds to the endothelial surface protease-activated 
receptor-1 (PAR-1) triggering a signaling cascade that results in the development of inter-endothelial 
junctional gaps that finally lead to an increase in endothelial permeability, the hallmark of tissue 
inflammation (120,121). The formation of these gaps is the result of cell-cell contact alteration: in 
particular, Ca2+ signaling is critical for PKCα activation in mediating disassembly of VE- cadherin 
junctions (122,123). Endothelial permeability is also decreased through a cell shape change induced by 
actinomyosin-mediated endothelial contraction: this endothelial 'rounding up' is mediated by Ca2+ 
entry via TRPC1 mediated by the monomeric GTP-binding protein RhoA (124). In summary, Rho 
activation signals interaction of IP3R with TRPC1 at the EC plasma membrane, and triggers Ca2+ 
entry following IP3-dependent store depletion (SOCE) and the resultant increase in endothelial 
permeability (124). It has been reported a similar causal link between the Gq-mediated increase in 
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cytosolic Ca2+ via TRPC6 and activation of RhoA, finally leading to the increase in endothelial 
permeability in response to Thrombin (125). This is an intriguing example involving an unusual 
scaffolding protein, Phosphatase and tensin homologue (PTEN). PTEN is a dual lipid-protein 
phosphatase that catalyzes the conversion of PIP3 to PIP2 and inhibits PI3K-Akt-dependent cell 
proliferation, migration, and tumor vascularization. Nonetheless, PTEN may play a role beyond 
suppressing PI3K signaling: in HPAEC it serves as a scaffold for TRPC6 through residues 394–403, 
enabling cell surface expression of the channel (126).  
TRPC4-dependent Ca2+ entry is another critical determinant of this process: indeed, both Ca2+ entry 
and lung microvascular permeability in response to Thrombin are drastically reduced in TRPC4-/- mice 
(127). In addition to TRPC1, TRPC6 and TRPC4, also the melastatin-family transient receptor 
potential 2 (TRPM2) channel regulates vascular permeability. TRPM2 is an oxidant-sensitive Ca2+ 
permeable channel that mediates H2O2-induced Ca2+ entry and endothelial hyperpermeability (128). 
Oxidants generated by activated EC are also known to induce apoptosis, a pathogenic feature of 
vascular injury and inflammation from multiple pathogeneses. The proapoptotic signaling mechanism 
involves reactive oxygen species–induced protein kinase C-α activation resulting in phosphorylation of 
the short splice variant TRPM2 (TRPM2-S) that allows enhanced TRPM2-mediated gating of Ca2+ 
and triggers the apoptosis program. Strategies aimed at preventing the uncoupling of TRPM2-S from 
TRPM2 and subsequent Ca2+ gating during oxidative stress may mitigate endothelial apoptosis and its 
consequences in mediating vascular injury and inflammation (129). Oxidative stress also increases the 
expression of TRPM7. This protein has the peculiar dual ability to act as a magnesium/calcium 
permeable channel and as a kinase through its functional α-kinase domain at the carboxyl terminus. For 
this reason it has been called, together with TRPM2, ‘chanzyme’ (130). TRPM7 permeability for Mg2+ 
is intriguing: in particular, an inhibitory effect of hypomagnesaemia on tumor growth and 
neoangiogenesis is under investigation (131). TRPM7 channels are expressed and functional in human 
EC. In HMEC low Mg2+ inhibits proliferation and migration without affecting metalloprotease 
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production and tridimensional organization: this effect is mediated, at least in part, by the decrease of 
TRPM7, since its silencing mimics the effects of Mg deficiency, thus suggesting TRPM7 as a possible 
contributor to the regulation of angiogenesis (132). The opposite effect has been observed in HUVEC: 
two independent reports have shown that siRNAs transiently silencing TRPM7 stimulate cell 
proliferation, a behavior which is unique to HUVEC, because in other cell types the same manipulation 
induces cell cycle arrest. In addition to the significant elevation of TRPM7 in the vasculature of MgL 
mice (a model of inherited hypomagnesemia), the increase of TRPM7 transcript in HUVEC exposed to 
shear stress has been described (133). TRPM7 silencing promotes endothelial growth/proliferation and 
nitric oxide production via the ERK pathway (134). The enzymatic kinase activity of TRPM7 might 
influence the ERK pathway although it is still not clear whether inhibition of TRPM7 channel also 
affects its kinase activity.   
Another ion channel interactor is the superfamily of G-proteins that are particularly relevant as a 
physical link to cell signaling (135). An interesting example is provided by the metabotropic glutamate 
receptor-1 (mGluR1) that may play a key role in regulating EC phenotype during tumor-induced 
angiogenesis. A loss of mGluR1 expression and activity is associated with an anti-angiogenic phenotype 
and tumor suppression (136). Despite the lack of information on PPI between mGluR1 and 
endothelial transportome this interaction seems likely since in Purkinje cells mGluR1 is physically 
associated and activates TRPC1 (137). 
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Interactions between channels and transporters 
The functional/physical coupling of ion channels with transporters seems to contribute to the 
neovascularization of healthy and tumoral tissues. Some examples involve Na/Ca (NCX) and Na/H 
(NHE) exchangers, two broadly expressed carriers that regulate intracellular calcium and proton 
homeostasis respectively (138–140). In transfected HEK cells Na+ entry mediated by TRPC3 enables 
local Na+ accumulation that drives Ca2+ entry via reverse mode NCX. This functional interaction is 
probably mediated by a tight physical interaction between TRPC3 and NCX1, suggesting a close 
spatial proximity between these ion transport systems (141,142). In EC from excised rat aorta the 
reverse mode NCX mediates, in cooperation with ATP-sensitive potassium channels, KATP, calcium 
signals activated by hydrogen sulfide, a gaseous bioactive messenger that has been implicated in tumor 
angiogenesis (74,141,142). Intriguingly, reverse mode NCX could also be triggered by voltage-
dependent sodium channels in endothelium. Voltage-gated Na+ channels (NaV) have long been 
considered as being characteristic of excitable cells: however, different NaV isoforms have been found in 
non-excitable cancer cells and their function enhances cancer cell invasiveness (145,146). Nav 1.5 
isoform is expressed and functional in HUVEC and mediates multiple angiogenic functions. In 
particular, it adjusts membrane potential and potentiates VEGF-induced ERK1/2 activation through 
the PKCα-B-RAF signaling (74,143,144). Accordingly, Ca2+ influx through reverse mode NCX is also 
required for the activation and targeting of PKCα to the plasma membrane, an essential step for 
VEGF-induced ERK1/2 phosphorylation and downstream EC functions in angiogenesis (147). 
Whether the voltage-gated sodium channel contribution to agonist-induced ERK1/2 activation is 
specific to VEGF and ECs remains to be elucidated. 
In addition to NCX, voltage-gated sodium channels can also interact with the Na+/H+ 
exchanger NHE1. In highly invasive breast cancer cells and high-grade breast cancer biopsies, the 
overexpression of the NaV1.5 isoform has been associated with extracellular matrix remodeling and the 
increased probability of developing metastases (145,146,148). The proteolytic activity of invadopodia is 
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highly dependent on the acidification of the peri-invadopodial extracellular compartment through the 
localized activity of NHE1 (140,149,150). NHE1 is known to have a substantial role in extracellular 
acidification and in the invasiveness of cancer cells. In highly invasive breast cancer cells MDA-MB-231, 
NaV1.5 interacts with and allosterically increases NHE1 activity in a pHi range between 6.4 and 7.0: 
this interaction is localized in focal ECM degradation sites corresponding to caveolin-1-containing 
invadopodia (148). In addition, NaV1.5 activity controls Src kinase activity, cortactin phosphorylation 
and actin cytoskeleton dynamics (148). NHE1 may be directly involved in angiogenesis. HIF-1 
overexpression upregulates VEGF, NHE1 and calpains in HUVEC and thus enhances endothelial 
proliferation, migration, and tube formation (151). Furthermore, suppression of NHE1 reduces 
calpain-2 expression and activity, finally leading to inhibition of HIF-1-induced angiogenesis. In 
addition to its canonical function, NHE1 can act as an anchor for actin filaments to control the 
integrity of the cortical cytoskeleton (152). This occurs through a structural link between NHE1 and 
the actin-binding proteins ERM. NHE1 and ERM proteins associate directly and colocalize in 
lamellipodia. Notably, fibroblasts expressing NHE1 with mutations that disrupt ERM binding, but not 
ion translocation, have impaired organization of focal adhesions and an irregular cell shape. It could be 
interesting to investigate non-canonical NHE activities in angiogenesis.  
 Finally, although no data are available so far concerning the potential interaction between ICT 
and ion pumps as a component of angiogenic signaling, in other tissues some examples have been 
reported. In the brain and kidney TRPC6 and the Na+/K+ ATPase are part of a functional complex 
that may be involved in ion transport and homeostasis (153). 
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Conclusions 
The post-genomic era is witnessing an explosive accumulation of biological data. At the same time, 
several public databases offer the opportunity to access such a wide range of biologically relevant 
literature on biomolecules and their expression, structure, location and interaction with other biological 
components. These novelties have attracted research focus towards data analysis and mining, in which 
the extraction of robust and suitable information from sparse and non-homogeneous sources is 
currently the main challenge. We often look at data- and hypothesis-driven methods as dichotomic 
strategies because they are hard to be integrated. Data-driven methods afford the view of the molecular 
makeup of biological systems and insight into biological phenomena but they are difficult to be 
combined to perform controlled experiments for testing hypotheses and, thus, to solve specific 
questions in biology. Therefore, the protein-protein network approach is a promising alternative that 
allows us to formulate testable hypotheses and to design validating experimental settings. In addition, 
since physiological and altered functions are regulated across many orders of magnitude in space and 
time, quantitative computational multi-scale modeling is increasingly adopted by researchers as a 
valuable descriptive and predictive tool in systems biology (154–158). 
Unfortunately, the systems biology viewpoint is still poorly employed in the biology of 
transportome in cancer. A simple explanation of the delay is that the research focused on membrane 
transport has been far from the field of experimental oncology for long time. Only very recently these 
two domains converged and an increasing amount of experimental data is currently available on 
canonical and non-canonical roles of ion channels in tumor vascularization. Thus, ICT are still under-
represented in interactomic databases when compared to other protein families with a longer tradition 
in oncology (receptors, kinases, phospholipase, transcription factors and others). Consequently, very 
few human proteins involved in membrane transportare annotated as components of cancer- and 
angiogenesis-associated signaling pathways, with the partial exception of TRP channels.  
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More theoretical and experimental effort will be needed to acquire a network perspective of 
transportome hopefully leading to a significant advancement in basic biology and oncology. 
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